RESCUE HEARING INC
GAINESVILLE, FLORIDA

Rescue Hearing Inc (RHI) is a pioneering company established to develop and monetize breakthrough technologies within the field of hearing loss. Founded by Mr. Caesar J. Ayala, who brings over two decades of healthcare industry experience, RHI seeks to revolutionize the treatment landscape for hearing loss conditions. With a strategic focus on integrating state-of-the-art gene therapy, small molecule research, imaging, and diagnostics, the company aims to build a diversified asset portfolio specifically tailored to address auditory health challenges. RHI is committed to staying at the forefront of enabling technologies such as CRISPR/Cas9 for gene editing, which promises realistic and cost-effective gene therapy solutions. Additionally, the reduction in consumer costs associated with genetic testing facilitates accurate identification of causative genetic mutations related to hearing loss. Under Mr. Ayala’s leadership, who previously guided significant healthcare projects like those at NxPharmaGen and Bradmer Pharmaceuticals, RHI is poised not only to develop and market its initial product platform but also to innovate follow-on products that leverage cumulative experiences. Based in Gainesville, Florida, with a mission statement focused on 'Eliminating Hearing Loss as a Chronic Condition,' RHI emphasizes continuous improvement and innovation. The company encourages engagement through regular updates on its latest news via social media and newsletter sign-ups. RHI's official operations commenced on August 25, 2017, and remain dynamic and growth-oriented, reflected in the filing numbers and reports submitted to regulatory bodies such as Florida's Division of Corporations. With its base at PO BOX 357391, Gainesville, FL, Rescue Hearing Inc is a registered entity under Fei Number: 81-2258943, adhering to company law compliance for corporations organized in domestic mode (DOMP). Mr. Ayala serves as the CEO, steering RHI towards impactful and life-enhancing solutions for individuals affected by hearing loss.